Key Players in the Bioabsorbable Stents Market

The bioabsorbable stent market comprises of a fewer number of players. Prominent players in the bioabsorbable stent market include Abbott (U.S.), Elixir Medical Corporation (U.S.), Kyoto Medical Co. LTD. (Japan), Reva Medical Inc. (U.S.), Arterial Remodeling Technologies (France), Tepha Inc. (U.S.), Meril Life Sciences Pvt. Ltd. (India) among others.

Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=40983380

Companies are focusing on various organic and inorganic growth strategies such as new product launches, agreements, partnerships & collaborations, and investments. New product launches & approvals accounted for the largest share of the overall growth strategies mapped from 2014 to 2016.

Various other products were launched during this period. For instance, in May 2015, Abbott received CE mark approval for Absorb GT1, which is the world’s first fully bioresorbable stent system. This approval helped the company to market this product in Europe, thus expanding its customer base.

Key players that adopted this strategy include Elixir Medical Corporation (U.S.), and Arterial Remodeling Technologies (France).

Geographically, the bioresorbable stents market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). In 2017, Europe is expected to dominate the market, followed by Asia. The dominance of European region is majorly attributed to increasing regulatory approvals for stents which will facilitate their commercialization and rising research activities for development of bioresorbable stents.

To Know More @ https://www.marketsandmarkets.com/Market-Reports/bioabsorbable-stent-market-40983380.html